New


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
15 11 2022
Historique:
pubmed: 6 10 2022
medline: 18 11 2022
entrez: 5 10 2022
Statut: ppublish

Résumé

The development and spread of drug-resistant phenotypes substantially threaten malaria control efforts. Combination therapies have the potential to minimize the risk of resistance development but require intensive preclinical studies to determine optimal combination and dosing regimens. To support the selection of new combinations, we developed a novel

Identifiants

pubmed: 36197116
doi: 10.1128/aac.00556-22
pmc: PMC9664866
doi:

Substances chimiques

Antimalarials 0
ferroquine 8D81JS19ET
artefenomel RIK029813G
Drug Combinations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0055622

Références

Malar J. 2013 Sep 18;12:332
pubmed: 24044530
Curr Protoc Chem Biol. 2016 Mar 16;8(1):29-58
pubmed: 26995353
J Antimicrob Chemother. 2007 Feb;59(2):197-203
pubmed: 17105736
PLoS One. 2011;6(7):e21237
pubmed: 21779323
BMC Med. 2017 Oct 9;15(1):181
pubmed: 28988541
Antimicrob Agents Chemother. 2001 Nov;45(11):3175-81
pubmed: 11600374
J Infect Dis. 2021 Jun 15;223(12):2154-2163
pubmed: 33119072
Nature. 1995 Mar 16;374(6519):269-71
pubmed: 7885447
Lancet Infect Dis. 2018 Aug;18(8):874-883
pubmed: 29909069
Acta Trop. 2005 Sep;95(3):305-15
pubmed: 16098946
PLoS One. 2012;7(2):e30949
pubmed: 22383983
Malar J. 2013 Jul 12;12:239
pubmed: 23849006
Pharm Res. 2015 Jul;32(7):2410-8
pubmed: 25630818
Exp Parasitol. 2007 Mar;115(3):296-300
pubmed: 17087929
Malar J. 2021 May 19;20(1):222
pubmed: 34011358
Malar J. 2021 Feb 16;20(1):93
pubmed: 33593375
Trends Parasitol. 2020 May;36(5):413-426
pubmed: 32298629
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 32041711
Commun Biol. 2021 Nov 25;4(1):1328
pubmed: 34824393
PLoS One. 2008 May 21;3(5):e2252
pubmed: 18493601
AAPS J. 2018 Jun 21;20(4):77
pubmed: 29931471
Malar J. 2015 Nov 05;14:441
pubmed: 26542470
Southeast Asian J Trop Med Public Health. 2010 Jul;41(4):761-9
pubmed: 21073050
Malar J. 2014 Oct 20;13:412
pubmed: 25331683
Malar J. 2012 Jul 20;11:235
pubmed: 22818754
Science. 1976 Aug 20;193(4254):673-5
pubmed: 781840
Biochem Pharmacol. 2005 Oct 15;70(8):1158-66
pubmed: 16139253
Antimicrob Agents Chemother. 2009 Oct;53(10):4533-6
pubmed: 19596869
Nat Commun. 2017 Dec 14;8(1):2129
pubmed: 29242552

Auteurs

Sebastian G Wicha (SG)

Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.

Annabelle Walz (A)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Mohammed H Cherkaoui-Rbati (MH)

Medicines for Malaria Venturegrid.452605.0, Geneva, Switzerland.

Nils Bundgaard (N)

IntiQuan GmbH, Basel, Switzerland.

Karsten Kuritz (K)

IntiQuan GmbH, Basel, Switzerland.

Christin Gumpp (C)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Nathalie Gobeau (N)

Medicines for Malaria Venturegrid.452605.0, Geneva, Switzerland.

Jörg Möhrle (J)

Medicines for Malaria Venturegrid.452605.0, Geneva, Switzerland.

Matthias Rottmann (M)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Claudia Demarta-Gatsi (C)

Medicines for Malaria Venturegrid.452605.0, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH